Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Gilead Sciences, Inc. (GILD) vs Nucor Corporation (NUE) Price & Performance

Gilead Sciences, Inc.Trade
Nucor CorporationTrade

Price performance (Past 24H)

Key statistics

Gilead Sciences, Inc. vs Nucor Corporation — how do they compare? Gilead Sciences, Inc. trades at $135.41 (market cap $168.35B), while Nucor Corporation trades at $271.95 (market cap $61.93B). The key difference: Gilead Sciences, Inc. is far larger — about 2.7× Nucor Corporation's market cap, and Gilead Sciences, Inc. pays the higher dividend (2.42%). Which is the better fit depends on your goals.

GILDNUE
Market Cap
$168.35B$61.93B
Sector
HealthBasic Materials
52-Week High
$155.80$274.74
52-Week Low
$110.56$131.78
Enterprise Value
$191.42B$66.34B
Dividend Yield
2.42%0.82%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Gilead Sciences, Inc.

Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.

Read more on GILD

About Nucor Corporation

Nucor Corp manufactures steel and steel products. The company also produces direct reduced iron for use in its steel mills. The operations include international trading and sales companies that buy and sell steel and steel products manufactured by the company and others. The operating business segments are: steel mills, steel products and raw materials, the steel mills segment derives maximum revenue.

Read more on NUE